Table 2.
CLL Cells Patient No. | Dorsomorphin (µM) | MRT68921 (µM) | Chloroquine (µM) | |||
---|---|---|---|---|---|---|
24 h | 48 h | 24 h | 48 h | 24 h | 48 h | |
1 | 6.4 | 4.9 | 3.7 | 3.4 | 16.0 | 5.6 |
2 | 5.2 | 4.4 | 3.0 | 2.6 | 14.0 | 8.8 |
3 | 5.9 | 3.0 | 3.7 | 2.7 | 23.8 | 13.7 |
4 | 6.5 | 5.4 | 4.1 | 2.3 | 13.1 | 10.1 |
5 | 7.8 | 5.5 | 5.2 | 4.5 | 60.1 | 22.3 |
6 | 4.4 | 3.5 | 3.2 | 1.8 | 60.8 | 14.3 |
7 | 7.3 | 3.1 | 4.8 | 3.4 | 21.3 | 7.3 |
8 | 6.5 | 3.7 | 3.8 | 2.6 | 53.1 | 23.5 |
9 | 8.6 | 5.6 | 4.8 | 4.0 | 19.9 | 4.1 |
10 | 5.0 | 2.8 | 4.8 | 3.3 | 46.4 | 7.6 |
11 | 3.1 | 2.0 | 1.0 | 0.2 | 4.1 | 2.1 |
12 | 12.2 | 11.1 | 8.0 | 7.5 | 46.3 | 24.0 |
13 | 1.8 | 1.6 | 1.2 | 0.7 | 6.6 | 4.6 |
14 | 14.2 | 9.6 | 10.8 | 9.7 | 60.4 | 23.1 |
15 | 6.5 | 4.4 | 4.5 | 3.4 | 29.7 | 14.3 |
16 | 6.4 | 5.2 | 4.2 | 3.4 | >100 | 45.2 |
17 | 2.6 | 2.9 | 1.6 | 1.3 | 28.4 | 19.4 |
18 | 8.5 | 7.5 | 5.7 | 5.2 | 37.0 | 24.9 |
19 | 12.4 | 7.6 | 8.9 | 6.8 | 92.7 | 29.3 |
20 | 3.6 | 3.0 | 3.6 | 3.5 | 21.1 | 13.4 |
21 | 9.0 | 4.5 | 5.6 | 2.5 | 54.9 | 16.7 |
22 | 2.9 | 2.0 | 1.3 | 1.3 | 22.4 | 8.5 |
23 | 7.0 | 5.3 | 3.7 | 3.2 | 32.8 | 19.1 |
24 | 9.9 | 9.2 | 6.5 | 5.0 | >100 | 67.4 |
25 | 5.1 | 3.9 | 2.4 | 1.2 | 51.5 | 22.0 |
26 | 3.5 | 2.0 | 4.3 | 4.0 | 18.5 | 9.0 |
27 | 3.7 | 3.1 | 3.2 | 3.0 | 31.9 | 24.9 |
28 | 2.7 | 2.6 | 2.4 | 2.3 | 30.9 | 11.9 |
Mean ± SD | 6.4 ± 3.1 | 4.6 ± 2.4 | 4.3 ± 2.3 | 3.4 ± 2.1 | 34.5 ± 20.8 | 17.8 ± 13.6 |